Compare · BGLC vs HUM
BGLC vs HUM
Side-by-side comparison of BioNexus Gene Lab Corp (BGLC) and Humana Inc. (HUM): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both BGLC and HUM operate in Medical Specialities (Health Care), so they compete in similar markets.
- HUM is the larger of the two at $46.33B, about 21744.2x BGLC ($2.1M).
- HUM has been more active in the news (19 items in the past 4 weeks vs 1 for BGLC).
- HUM has more recent analyst coverage (25 ratings vs 0 for BGLC).
- Company
- BioNexus Gene Lab Corp
- Humana Inc.
- Price
- -
- -
- Market cap
- $2.1M
- $46.33B
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Medical Specialities
- Medical Specialities
- Exchange
- NASDAQ
- NYSE
- IPO
- News (4w)
- 1
- 19
- Recent ratings
- 0
- 25
Humana Inc.
Humana Inc., together with its subsidiaries, operates as a health and well-being company in the United States. It operates through Retail, Group and Specialty, and Healthcare Services segments. The company offers medical and supplemental benefit plans to individuals. It also has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits. In addition, the company provides commercial fully-insured medical and specialty health insurance benefits comprising dental, vision, and other supplemental health benefits; and administrative services only products to individuals and employer groups, as well as military services, such as TRICARE T2017 East Region contract. Further, it offers pharmacy solutions, provider services, predictive modeling and informatics services, and clinical care services, such as home health and other services to its health plan members, as well as to third parties. As of December 31, 2020, the company had approximately 17 million members in medical benefit plans, as well as approximately 5 million members in specialty products. Humana Inc. was incorporated in 1964 and is headquartered in Louisville, Kentucky.
Latest BGLC
- BioNexus Launches New Corporate Website with Expanded Business and Investor Resources
- SEC Form 8-K filed by BioNexus Gene Lab Corp
- RYET to Enter Malaysian Healthcare Through Exclusive Cogni AI License to BioNexus Gene Lab
- Chief Executive Officer Tan Lee Su-Leng was granted 338,709 shares (SEC Form 4)
- Director Yap Chee Keong was granted 32,258 shares (SEC Form 4)
- Director Bin Abdul Hamid Muhammad Azrul was granted 32,258 shares (SEC Form 4)
- Chief Financial Officer Chong Set Fui was granted 96,774 shares (SEC Form 4)
- Director Low Jook Yuen was granted 16,129 shares, increasing direct ownership by 1,279% to 17,390 units (SEC Form 4)
- SEC Form 10-Q filed by BioNexus Gene Lab Corp
- New insider Fidelion Diagnostics Pte. Ltd. claimed ownership of 392,329 shares (SEC Form 3)
Latest HUM
- Before the Bell: Rate-Hike Signals, Health Insurer Losses and Cyber Gains
- Florida Seniors and Primary Care Providers Agree that Prevention, Affordable Care and Comprehensive Coverage are Keys to Healthy Aging
- Humana Foundation Marks 45 Years With Nearly $14 Million in Grants to Expand Healthy Food Access and Help Seniors Feel More Connected
- Humana to Launch National Gold Card Program to Reduce Prior Authorization Requirements
- Humana Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits
- Humana Announces Final Results of Offers to Purchase for Cash Certain of its Outstanding Debt Securities
- Humana Announces Pricing Terms of Offers to Purchase for Cash Certain of its Outstanding Debt Securities
- Humana upgraded by RBC Capital Mkts with a new price target
- Director Frederick Wayne A.I. sold $193,853 worth of Humana Common (440 units at $440.57), closing all direct ownership in the company (SEC Form 4)
- President, Enterprise Growth Dintenfass David gifted 230 units of Humana Common, decreasing direct ownership by 0.91% to 25,177 units (SEC Form 4)